GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
Subodh Verma
https://orcid.org/0000-0002-4018-8533
Department of Pharmacology and Toxicology (S.V.), University of Toronto, Canada.
Institutes of Medical Sciences (S.V.), University of Toronto, Canada.
Department of Surgery (S.V.), University of Toronto, Canada.
Division of Cardiovascular Surgery, St Michael’s Hospital, Toronto, Canada (S.V).
Comments (0)